IBDEI15U ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18835,0)
 ;;=J84.117^^64^841^7
 ;;^UTILITY(U,$J,358.3,18835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18835,1,3,0)
 ;;=3^Desquamative Interstitial Pneumonia
 ;;^UTILITY(U,$J,358.3,18835,1,4,0)
 ;;=4^J84.117
 ;;^UTILITY(U,$J,358.3,18835,2)
 ;;=^340540
 ;;^UTILITY(U,$J,358.3,18836,0)
 ;;=M32.0^^64^841^8
 ;;^UTILITY(U,$J,358.3,18836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18836,1,3,0)
 ;;=3^Drug-Induced Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,18836,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,18836,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,18837,0)
 ;;=M32.11^^64^841^9
 ;;^UTILITY(U,$J,358.3,18837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18837,1,3,0)
 ;;=3^Endocarditis in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,18837,1,4,0)
 ;;=4^M32.11
 ;;^UTILITY(U,$J,358.3,18837,2)
 ;;=^5011754
 ;;^UTILITY(U,$J,358.3,18838,0)
 ;;=J67.0^^64^841^10
 ;;^UTILITY(U,$J,358.3,18838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18838,1,3,0)
 ;;=3^Farmer's Lung
 ;;^UTILITY(U,$J,358.3,18838,1,4,0)
 ;;=4^J67.0
 ;;^UTILITY(U,$J,358.3,18838,2)
 ;;=^44962
 ;;^UTILITY(U,$J,358.3,18839,0)
 ;;=M32.14^^64^841^11
 ;;^UTILITY(U,$J,358.3,18839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18839,1,3,0)
 ;;=3^Glomerular Disease in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,18839,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,18839,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,18840,0)
 ;;=J67.9^^64^841^12
 ;;^UTILITY(U,$J,358.3,18840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18840,1,3,0)
 ;;=3^Hypersensitivity Pneumonitis d/t Unspec Organic Dust
 ;;^UTILITY(U,$J,358.3,18840,1,4,0)
 ;;=4^J67.9
 ;;^UTILITY(U,$J,358.3,18840,2)
 ;;=^5008280
 ;;^UTILITY(U,$J,358.3,18841,0)
 ;;=J84.113^^64^841^14
 ;;^UTILITY(U,$J,358.3,18841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18841,1,3,0)
 ;;=3^Idiopathic Non-Specific Interstitial Pneumonitis
 ;;^UTILITY(U,$J,358.3,18841,1,4,0)
 ;;=4^J84.113
 ;;^UTILITY(U,$J,358.3,18841,2)
 ;;=^340535
 ;;^UTILITY(U,$J,358.3,18842,0)
 ;;=J84.112^^64^841^15
 ;;^UTILITY(U,$J,358.3,18842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18842,1,3,0)
 ;;=3^Idiopathic Pulmonary Fibrosis
 ;;^UTILITY(U,$J,358.3,18842,1,4,0)
 ;;=4^J84.112
 ;;^UTILITY(U,$J,358.3,18842,2)
 ;;=^340534
 ;;^UTILITY(U,$J,358.3,18843,0)
 ;;=J84.111^^64^841^13
 ;;^UTILITY(U,$J,358.3,18843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18843,1,3,0)
 ;;=3^Idiopathic Interstitial Pneumonia NOS
 ;;^UTILITY(U,$J,358.3,18843,1,4,0)
 ;;=4^J84.111
 ;;^UTILITY(U,$J,358.3,18843,2)
 ;;=^340610
 ;;^UTILITY(U,$J,358.3,18844,0)
 ;;=J84.9^^64^841^18
 ;;^UTILITY(U,$J,358.3,18844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18844,1,3,0)
 ;;=3^Interstitial Pulmonary Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18844,1,4,0)
 ;;=4^J84.9
 ;;^UTILITY(U,$J,358.3,18844,2)
 ;;=^5008304
 ;;^UTILITY(U,$J,358.3,18845,0)
 ;;=M32.13^^64^841^19
 ;;^UTILITY(U,$J,358.3,18845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18845,1,3,0)
 ;;=3^Lung Involvement in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,18845,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,18845,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,18846,0)
 ;;=J84.2^^64^841^20
 ;;^UTILITY(U,$J,358.3,18846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18846,1,3,0)
 ;;=3^Lymphoid Interstitial Pneumonia
 ;;^UTILITY(U,$J,358.3,18846,1,4,0)
 ;;=4^J84.2
 ;;^UTILITY(U,$J,358.3,18846,2)
 ;;=^5008302
